Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers (HART-HN)

NCT05120947 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT05120947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05120947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers (HART-HN)
Lead sponsor
Medical College of Wisconsin
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2021
Completion date
November 22, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable head and neck squamous cell carcinoma